356 related articles for article (PubMed ID: 7612231)
1. Superantigens of mouse mammary tumor virus.
Acha-Orbea H; MacDonald HR
Annu Rev Immunol; 1995; 13():459-86. PubMed ID: 7612231
[TBL] [Abstract][Full Text] [Related]
2. A V beta 4-specific superantigen encoded by a new exogenous mouse mammary tumor virus.
Maillard I; Erny K; Acha-Orbea H; Diggelmann H
Eur J Immunol; 1996 May; 26(5):1000-6. PubMed ID: 8647159
[TBL] [Abstract][Full Text] [Related]
3. B and T cells are required for mouse mammary tumor virus spread within the mammary gland.
Golovkina TV; Dudley JP; Ross SR
J Immunol; 1998 Sep; 161(5):2375-82. PubMed ID: 9725233
[TBL] [Abstract][Full Text] [Related]
4. CD28/CTLA4-B7 interaction is dispensable for T cell stimulation by mouse mammary tumor virus superantigen but not for B cell differentiation and virus dissemination.
Champagne E; Scarpellino L; Lane P; Acha-Orbea H
Eur J Immunol; 1996 Jul; 26(7):1595-602. PubMed ID: 8766566
[TBL] [Abstract][Full Text] [Related]
5. Concomitant infection with exogenous mouse mammary tumor virus encoding I-E-dependent superantigen in I-E-negative mouse strain.
Ando Y; Wajjwalku W; Niimi N; Hiromatsu K; Morishima T; Yoshikai Y
J Immunol; 1995 Jun; 154(12):6219-26. PubMed ID: 7759859
[TBL] [Abstract][Full Text] [Related]
6. MHC class II hierarchy of superantigen presentation predicts efficiency of infection with mouse mammary tumor virus.
Held W; Waanders GA; MacDonald HR; Acha-Orbea H
Int Immunol; 1994 Sep; 6(9):1403-7. PubMed ID: 7819149
[TBL] [Abstract][Full Text] [Related]
7. The role of CD28 costimulation in immune-mediated responses against mouse mammary tumor viruses.
Palmer LD; Saha B; Hodes RJ; Abe R
J Immunol; 1996 Mar; 156(6):2112-8. PubMed ID: 8690899
[TBL] [Abstract][Full Text] [Related]
8. Presentation of the Mls-1 superantigen by human HLA class II molecules to murine T cells.
Subramanyam M; McLellan B; Labrecque N; Sekaly RP; Huber BT
J Immunol; 1993 Sep; 151(5):2538-45. PubMed ID: 8395548
[TBL] [Abstract][Full Text] [Related]
9. T cells bearing Vbeta8 are preferentially infected with exogenous mouse mammary tumor virus.
Upragarin N; Nishimura H; Wajjwalku W; Ando Y; Nagafuchi S; Watanabe T; Yoshikai Y
J Immunol; 1997 Sep; 159(5):2189-95. PubMed ID: 9278306
[TBL] [Abstract][Full Text] [Related]
10. Human T cells respond to mouse mammary tumor virus-encoded superantigen: V beta restriction and conserved evolutionary features.
Labrecque N; McGrath H; Subramanyam M; Huber BT; Sékaly RP
J Exp Med; 1993 Jun; 177(6):1735-43. PubMed ID: 8388432
[TBL] [Abstract][Full Text] [Related]
11. Exogenous mouse mammary tumor virus (MMTV) infection induces endogenous MMTV sag expression.
Xu L; Wrona TJ; Dudley JP
Virology; 1996 Jan; 215(2):113-23. PubMed ID: 8560758
[TBL] [Abstract][Full Text] [Related]
12. Mutational and functional analysis of the C-terminal region of the C3H mouse mammary tumor virus superantigen.
Wrona TJ; Lozano M; Binhazim AA; Dudley JP
J Virol; 1998 Jun; 72(6):4746-55. PubMed ID: 9573239
[TBL] [Abstract][Full Text] [Related]
13. Lack of MMTV superantigen presentation in MHC class II-deficient mice.
Beutner U; McLellan B; Kraus E; Huber BT
Cell Immunol; 1996 Mar; 168(2):141-7. PubMed ID: 8640859
[TBL] [Abstract][Full Text] [Related]
14. Thymic repertoire selection by superantigens: presentation by human and mouse MHC molecules.
Simpson E; Takacs K; Altmann DM
Thymus; 1994; 23(1):1-13. PubMed ID: 7863543
[TBL] [Abstract][Full Text] [Related]
15. Superantigen-reactive CD4+ T cells are required to stimulate B cells after infection with mouse mammary tumor virus.
Held W; Shakhov AN; Izui S; Waanders GA; Scarpellino L; MacDonald HR; Acha-Orbea H
J Exp Med; 1993 Feb; 177(2):359-66. PubMed ID: 8093892
[TBL] [Abstract][Full Text] [Related]
16. A V beta 8.2-specific superantigen from exogenous mouse mammary tumor virus carried by FM mice.
Yoshimoto T; Nagase H; Nakano H; Matsuzawa A; Nariuchi H
Eur J Immunol; 1994 Jul; 24(7):1612-9. PubMed ID: 7913038
[TBL] [Abstract][Full Text] [Related]
17. [Coevolutive mechanisms between retroviruses and their hosts. The murine mammary tumor model].
Nepomnaschy I; Buggiano V; Goldman A; Piazzon I
Medicina (B Aires); 1997; 57(2):235-44. PubMed ID: 9532836
[TBL] [Abstract][Full Text] [Related]
18. [Viral superantigens].
Us D
Mikrobiyol Bul; 2016 Jul; 50(3):491-504. PubMed ID: 27525406
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the Mlsf system. II. Identification of mouse mammary tumor virus proviruses involved in the clonal deletion of self-Mlsf-reactive T cells.
Foo-Phillips M; Kozak CA; Principato MA; Abe R
J Immunol; 1992 Dec; 149(11):3440-7. PubMed ID: 1331236
[TBL] [Abstract][Full Text] [Related]
20. A mouse mammary tumor virus-like long terminal repeat superantigen in human breast cancer.
Wang Y; Jiang JD; Xu D; Li Y; Qu C; Holland JF; Pogo BG
Cancer Res; 2004 Jun; 64(12):4105-11. PubMed ID: 15205319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
